Literature DB >> 1096840

Treatment of fungal infections with flucytosine.

E J Harder, P E Hermans.   

Abstract

Treatment with flucytosine of 20 patients with fungal infections gave favorable results in four patients with crytococcal infections, two of four patients with disseminated candidiasis, eight of ten patients with urinary tract infections due to Candida albicans and Torulopsis glabrata, and tow of three patients with miscellaneous infections due to Calbicans. Two patients with crytococcal meningitis and altered host resistance and one patient with an aorto femoral graft infection due to C albicans were treated with flucytosine and smphotericin B. The infection was eradicated in one of the patients with meningitis, and cultures from an infected arterial graft became negative. Adverse side effects of flucytosine included mild leukopenia and thrombocytopenia, a transient increase in alkaline phosphatase and glutamic oxaloacetic transaminase, and nausea and diarrhea.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1096840

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  8 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Case report 664. Cryptococcus neoformans osteomyelitis.

Authors:  F W Abdul-Karim; M N Pathria; J G Heller; R U Sorensen
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

3.  Toward a clinical antifungal peptoid: Investigations into the therapeutic potential of AEC5.

Authors:  Sabrina K Spicer; Aarthi Subramani; Angelica L Aguila; R Madison Green; Erin E McClelland; Kevin L Bicker
Journal:  Biopolymers       Date:  2019-04-02       Impact factor: 2.505

4.  Isolated cryptococcus osteomyelitis of the humerus simulating a neoplasm of bone in a patient with sarcoidosis. Case report 329.

Authors:  A M Levine; P Meier; H D Dorfman
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

Review 5.  Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation?

Authors:  Daniela Baracaldo-Santamaría; Juan David Cala-Garcia; Germán José Medina-Rincón; Luis Carlos Rojas-Rodriguez; Carlos-Alberto Calderon-Ospina
Journal:  Antibiotics (Basel)       Date:  2022-05-12

6.  Cryptococcal sacroiliitis.

Authors:  C Brand; R Warren; M Luxton; D Barraclough
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

Review 7.  Fungal urinary tract infections in the elderly: treatment guidelines.

Authors:  L G Jacobs
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

8.  Flucytosine for treatment of Candida albicans in H1N1-positive patient.

Authors:  Tanvir Samra; Amlendu Yadav; Neerja Banerjee; Mridula Pawar; Desh Deepak
Journal:  Indian J Pharmacol       Date:  2010-10       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.